Viatris Inc
NASDAQ:VTRS
Viatris Inc
NASDAQ:VTRS
Price:
10.39 USD
-0.19%
Market Closed
Updated:
May 29, 2024
Viatris Inc
Other Liabilities
|
Viatris Inc
Other Liabilities Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Viatris Inc
NASDAQ:VTRS
|
Other Liabilities
$1.8B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-4%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Liabilities
$25B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Liabilities
$6.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
|
|
Pfizer Inc
NYSE:PFE
|
Other Liabilities
$25.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Other Liabilities
$8.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
0%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Liabilities
$7.9B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
6%
|
See Also
What is Viatris Inc's Other Liabilities?
Other Liabilities
1.8B
USD
1.8B
USD
Based on the financial report for Mar 31, 2024, Viatris Inc's Other Liabilities amounts to 1.8B USD.
What is Viatris Inc's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
-4%
-4%
Over the last year, the Other Liabilities growth was 6%. The average annual Other Liabilities growth rates for Viatris Inc have been -10% over the past three years , 10% over the past five years , and -4% over the past ten years .
You don't have any saved screeners yet
